Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01136057 · ClinicalTrials.gov registry record
Blood and Plasma Collection For Use in Future Clinical Trials
A clinical trial, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- Completed
- Registry status
- 21
- Enrollment target
NCT01136057: Completed study, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
NCT01136057 is a clinical trial that has completed, run by National Institute of Allergy and Infectious Diseases (NIAID). The registered enrollment target is 21 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01136057 has completed, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- COMPLETED
- Registry status
- 21 participants
- Enrollment target
Study Summary
Treatment options are limited for the treatment of influenza. This study will collect blood from people who have been exposed to the influenza virus or who have received a seasonal influenza vaccine. The blood plasma will be used in a future clinical trial to treat people hospitalized with influenza.
Interventions
- BIOLOGICAL Collection of Anti-Influenza A Immune Plasma
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2010-04 |
| Est. Completion | 2019-01-04 |
What the finished NCT01136057 record still lists
NCT01136057 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 21 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Collection of Anti-Influenza A Immune Plasma is the first listed.
NCT01136057 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01136057 about?
NCT01136057 is a clinical study titled "Blood and Plasma Collection For Use in Future Clinical Trials". Treatment options are limited for the treatment of influenza. This study will collect blood from people who have been exposed to the influenza virus or who have received a seasonal influenza vaccine. The blood plasma will be used in a future clinical trial to treat people hospitalized with influenza...
What is the current status of trial NCT01136057?
This trial is currently completed. The enrollment target is 21 participants. The study started on 2010-04. Estimated completion is 2019-01-04.
What interventions are being tested in trial NCT01136057?
The interventions under investigation include: Collection of Anti-Influenza A Immune Plasma (BIOLOGICAL).
Who is sponsoring clinical trial NCT01136057?
This trial is sponsored by National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02447874 · 21 participants · Phase 1
Arginine Therapy for the Treatment of Pain in Children With Sickle Cell Disease
- NCT03826992 · 21 participants · Phase 1
Venetoclax Combined With Vyxeos (CPX-351) for Participants With Relapsed or Refractory Acute Leukemia
- NCT04107077 · 21 participants · Phase 2
Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer
- NCT04158635 · 21 participants · Phase 1
Gemcitabine, Nab-Paclitaxel, and Bosentan for the Treatment of Unresectable Pancreatic Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia